Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis

The concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy (NAC) has been proposed to improve the pathologic complete response (pCR) rate, although there are conflicting views about its efficacy and safety. The purpose of this study was to evaluate the efficacy and cardiac sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yu-Tuan, Xu, Zhou, Zhang, Ke, Wu, Jiu-song, Li, Xin, Arshad, Bilal, Li, Ying-Cun, Wang, Zhong-Liang, Li, Hong-Yuan, Wu, Kai-Nan, Kong, Ling-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165855/
https://www.ncbi.nlm.nih.gov/pubmed/30310287
http://dx.doi.org/10.2147/TCRM.S176214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165855/
https://www.ncbi.nlm.nih.gov/pubmed/30310287
http://dx.doi.org/10.2147/TCRM.S176214

Ejemplares similares